Allena Pharmaceuticals Inc. (ALNA)’s Financial Results Comparing With Neptune Wellness Solutions Inc. (NASDAQ:NEPT)

As Biotechnology businesses, Allena Pharmaceuticals Inc. (NASDAQ:ALNA) and Neptune Wellness Solutions Inc. (NASDAQ:NEPT), are affected by contrast. This especially applies to their dividends, analyst recommendations, profitability, risk, earnings and valuation, institutional ownership.

Valuation and Earnings

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Allena Pharmaceuticals Inc. 6 0.00 N/A -1.89 0.00
Neptune Wellness Solutions Inc. 4 0.00 N/A 0.00 0.00

Table 1 shows gross revenue, earnings per share (EPS) and valuation of the two companies.


Table 2 provides us Allena Pharmaceuticals Inc. and Neptune Wellness Solutions Inc.’s return on assets, return on equity and net margins.

Net Margins Return on Equity Return on Assets
Allena Pharmaceuticals Inc. 0.00% -73.3% -57.3%
Neptune Wellness Solutions Inc. 0.00% 0% 0%

Analyst Recommendations

The following table given below contains the ratings and recommendations for Allena Pharmaceuticals Inc. and Neptune Wellness Solutions Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Allena Pharmaceuticals Inc. 0 0 1 3.00
Neptune Wellness Solutions Inc. 0 0 0 0.00

Allena Pharmaceuticals Inc. has an average price target of $26, and a 494.97% upside potential.

Institutional and Insider Ownership

Roughly 88.1% of Allena Pharmaceuticals Inc. shares are owned by institutional investors while 17.35% of Neptune Wellness Solutions Inc. are owned by institutional investors. Insiders owned 8.27% of Allena Pharmaceuticals Inc. shares. Comparatively, 18.84% are Neptune Wellness Solutions Inc.’s share owned by insiders.


Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Allena Pharmaceuticals Inc. -4.88% -9.11% -32.51% -45.76% -60.9% -24.95%
Neptune Wellness Solutions Inc. -7.14% 32.41% 38.16% 73.86% 100.7% 125.2%

For the past year Allena Pharmaceuticals Inc. has -24.95% weaker performance while Neptune Wellness Solutions Inc. has 125.2% stronger performance.


On 4 of the 7 factors Neptune Wellness Solutions Inc. beats Allena Pharmaceuticals Inc.

Allena Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic, and kidney disorders in the United States. The companyÂ’s lead product candidate includes ALLN-177, an oral enzyme therapeutic for the treatment of enteric hyperoxaluria, a metabolic disorder commonly associated with kidney stones in adults. It is also involved in developing ALLN-346 for patients with hyperuricemia and moderate to severe chronic kidney diseases. The company was incorporated in 2011 and is headquartered in Newton, Massachusetts.

Neptune Technologies & Bioressources Inc., a nutrition products company, focuses on providing nutrition solutions, including specialty ingredients and consumer brands. The company develops solutions available in various delivery forms. It also offers various specialty ingredients, including premium krill oil and other marine oils, as well as seed oils. The company sells its premium krill oil under the OCEANO3 brand directly to consumers through in Canada and the United States. In addition, Neptune Technologies & Bioressources Inc. is pursuing opportunities in the prescription drug markets, through its subsidiary, Acasti Pharma Inc., that focuses on the research, development, and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment of severe hypertriglyceridemia. The company was founded in 1925 and is headquartered in Laval, Canada.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.